Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study-Reference-Cited by-同舟云学术

Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study

Published:2021-05-18 Issue:5 Volume:290 Page:1048-1060
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Ekberg S.¹^ORCID,Harrysson S.¹²^ORCID,Jernberg T.³^ORCID,Szummer K.⁴⁵^ORCID,Andersson P.‐O.⁶⁷,Jerkeman M.⁸^ORCID,Smedby K. E.¹²^ORCID,Eloranta S.¹^ORCID

Affiliation:

1. From the Division of Clinical Epidemiology Department of Medicine Solna Karolinska Institutet StockholmSweden

2. Department of Hematology Karolinska University Hospital SolnaSweden

3. Department of Clinical Sciences Danderyd University Hospital Karolinska Institutet StockholmSweden

4. Section of Cardiology Department of Medicine Karolinska Institutet StockholmSweden

5. Department of Cardiology Karolinska University Hospital StockholmSweden

6. Department of Hematology South Älvsborg Hospital BoråsSweden

7. Sahlgrenska Academy Gothenburg University GothenburgSweden

8. Division of Oncology Lund University and Skane University Hospital Lund Sweden

Funder

Cancerfonden

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13303

Reference31 articles.

1. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

4. Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

5. Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chest Computed Tomography for Lymphoma Staging: A Wasted Opportunity for Cardiovascular Risk Stratification?;Heart, Lung and Circulation;2024-05

2. Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma;Discover Oncology;2024-04-05

3. Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis;The American Journal of Cardiology;2024-02

4. Reproduction patterns among non‐Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population‐based matched cohort study;British Journal of Haematology;2023-06-16

5. Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients;Frontiers in Oncology;2023-06-09